Rosetta Genomics Ltd. (USA) operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Rosetta Genomics Ltd. (USA) with three other
pharmaceutical manufacturers in Middle East:
October Pharma For Pharmaceutical Industries SAE
sales of 288.11 million Egyptian Pounds [US$18.42 million]
Hayat Pharmaceutical Industries Company PSC
(10.54 million Jordanian Dinars [US$14.86 million]
Philadelphia Pharmaceuticals Industry Company PSC
based in JORDAN
(6.80 million Jordanian Dinars [US$9.59 million]
Rosetta Genomics Ltd. (USA) reported sales of 35.31 million Israel Shekels (US$10.80 million)
December of 2016.
increase of 9.9%
versus 2015, when the company's sales were 32.13 million Israel Shekels.
Sales at Rosetta Genomics Ltd. (USA) have increased during each of the previous five years
(and since 2011, sales have increased a total of 9,497%).